February 25, 2016: FemPulse Featured in MedTech Insight
FemPulse was featured in the February edition of MedTech Insights in an article titled “Neuromodulation Devices Stimulate Opportunities in Urology”. The article provided a comprehensive assessment of future innovation in the rapidly growing fields of neuromodulation for Overactive Bladder (OAB). While currently marketed devices provide effective therapy, they can be costly, invasive and require a […]
February 2, 2016: Third FemPulse Patent Granted
The US Patent Office has granted the third FemPulse patent (#9,248,285). This broad patent grants claims regarding stimulation of nerves adjacent the vaginal canal to stimulate the autonomic plexuses, as well as claims regarding controllers and sensors.
February 1, 2016: Don Deyo Named FemPulse CEO
Don Deyo joined FemPulse in the newly created role of Chief Executive Officer. Don is a 29-year veteran of Medtronic, PLC, where he served in a variety of executive leadership roles. He is founder and CEO of the consultancy firm, MedTech Execs and was CEO of Medallion Therapeutics, Inc. prior to joining FemPulse. Don brings […]
December 31, 2015: FemPulse Completes Financing
FemPulse completed a private financing round to support the company’s clinical, regulatory and R&D objectives. The round, which was oversubscribed, brought in experienced, value-add investors who are expected to contribute to the success of the company.
December 10, 2015: Dr. Haessler speaks at North American Neuromodulation Society Conference
FemPulse was invited to present during the I3 forum sponsored by the North American Neuromodulation Society. I3, representing Innovation, Investment and Invigoration, provides a fitting context for a presentation regarding this leading edge company. The FemPulse system is a first-of- its-kind wearable neuromodulation system providing discrete, simple and continuous neuromodulation therapy for OAB. Dr. Haessler […]
November 3, 2015: Dr. Haessler speaks at Neurotech Leaders Forum
FemPulse was one of seven companies featured in the 14th annual Neurotech Leaders Forum. This year’s meeting included a day dedicated to the rapidly expanding field of wireless, noninvasive neuromodulation technology. FemPulse is on the forefront of this revolution.
August 23, 2015: Ben Pless joins FemPulse Advisory Board
Ben joined the five other medical and medical device experts on the FemPulse Advisory Board, after previously advising the founders informally. Ben is an MIT-educated engineer, who has become a leading medical device executive and innovator in Silicon Valley over the past 30 years. Ben has served as Vice President of product development at Ventritex […]
June 9, 2015: Don Deyo and Darrin Uecker Join FemPulse Advisory Board
Two senior medical device executives, Don Deyo and Darrin Uecker, have joined the FemPulse Advisory Board. Don and Darrin each bring over 20 years of experience in developing and launching innovative medical devices. Dr. Alexandra Haessler, founder of FemPulse, said: “Don brings deep technical and neuromodulation industry experience. Darrin will bring his broad medical device […]
June 6, 2015: Dr. Haessler of FemPulse presents at INS World Congress
FemPulse is one of only ten companies from around the world selected to present at the International Neuromodulation Society (INS) “Innovations in Neuromodulation” panel on June 6, 2015 in Montreal. This biennial event is part of INS’s 12th World Congress, featuring the most innovative neuromodulation companies. Dr. Alexandra Haessler, founder of FemPulse, is presenting the […]
